Booster doses 12 yo 1 dose 30 g 5mo after primary series may give heterologous booster doses if 18 yo and older but eligibility criteria and dosing interval should follow primary series product if moderately severely immunocompromised give 3mo after prima

By vgreene, 24 September, 2021
Detail (Long)
<b>Booster doses (≥12 yo):</b> 1 dose (30 μg) ≥5mo after primary series (may give heterologous booster doses if 18 yo and older, but eligibility criteria and dosing interval should follow primary series product); if moderately-severely immunocompromised, give 3mo after primary series; in pts ≥50 yo or moderately-severely immunocompromised pts, give 2nd dose (30 μg) >4mo after 1st dose